Journal of Personalized Medicine

metrics 2024

Exploring the frontiers of individualized medicine.

Introduction

Journal of Personalized Medicine is a pioneering open-access journal published by MDPI, renowned for its commitment to advancing research in the dynamic field of personalized healthcare. Since its inception in 2011, this journal has served as a critical platform for scholars, practitioners, and students interested in the integration of individualized therapies and diagnostic techniques that aim to tailor medical treatments to the unique characteristics of each patient. With an impressive Q2 ranking in the field of medicine, as recognized by Scopus, and currently holding a percentile rank of 65th, it stands out among its peers with a focus on innovative approaches that challenge traditional paradigms. Researchers can benefit from its open-access model, allowing for broader dissemination of findings that can significantly impact clinical practices and research directions globally. Set against the picturesque backdrop of Basel, Switzerland, the journal is positioned at the forefront of medical innovation, producing high-quality, peer-reviewed articles that span the latest advancements and applications in personalized medicine.

Metrics 2024

SCIMAGO Journal Rank-
Journal Impact Factor3.00
Journal Impact Factor (5 years)3.00
H-Index-
Journal IF Without Self3.00
Eigen Factor0.02
Normal Eigen Factor4.61
Influence0.68
Immediacy Index0.70
Cited Half Life2.00
Citing Half Life6.50
JCI1.05
Total Documents-
WOS Total Citations12728
SCIMAGO Total Citations-
SCIMAGO SELF Citations-
Scopus Journal Rank-
Cites / Document (2 Years)-
Cites / Document (3 Years)-
Cites / Document (4 Years)-

Metrics History

Rank 2024

IF (Web Of Science)

HEALTH CARE SCIENCES & SERVICES
Rank 51/174
Percentile 71.00
Quartile Q2
MEDICINE, GENERAL & INTERNAL
Rank 58/325
Percentile 82.30
Quartile Q1

JCI (Web Of Science)

HEALTH CARE SCIENCES & SERVICES
Rank 39/175
Percentile 77.71
Quartile Q1
MEDICINE, GENERAL & INTERNAL
Rank 48/329
Percentile 85.41
Quartile Q1

Quartile History

Similar Journals

Cancer Management and Research

Pioneering new paths in cancer management and research.
Publisher: DOVE MEDICAL PRESS LTDISSN: 1179-1322Frequency: 1 issue/year

Cancer Management and Research, published by DOVE MEDICAL PRESS LTD, is a leading open-access journal dedicated to advancing the field of oncology. Since its inception in 2009, this journal has established itself as a vital resource for researchers, clinicians, and healthcare professionals focused on cancer treatment and management. With its robust impact factor and impressive Scopus ranking in the 77th percentile of oncology medicine, it provides a prominent platform for sharing high-quality research. The journal covers a wide range of topics within cancer management, including innovative therapeutic strategies, clinical trials, patient care, and health policy, ensuring a comprehensive approach to current challenges in the field. Operating from New Zealand, it invites contributions that can shape the future of oncology and improve patient outcomes globally, making it an essential addition to the libraries of those engaged in cancer research and practice.

Onkologie

Exploring Innovations in Cancer Care and Research.
Publisher: SPRINGER HEIDELBERGISSN: 2731-7226Frequency: 12 issues/year

Onkologie is a peer-reviewed academic journal published by SPRINGER HEIDELBERG, focusing on the evolving fields of Oncology and Hematology. Established as a significant platform for the dissemination of research in these crucial areas of medicine, Onkologie aims to provide insights into the latest advancements, therapeutic strategies, and clinical practices that shape patient care in oncology and hematology. Despite its current placement in the Q4 category for both disciplines, this journal aspires to foster scholarly dialogues and enhance its contributions to the scientific community. The journal is based in Germany and encourages submissions that promote a deeper understanding of oncology's complex landscape, ensuring that researchers, clinicians, and students have access to a wealth of knowledge essential for clinical practice and further research. With an ISSN of 2731-7226 and E-ISSN of 2731-7234, Onkologie is committed to maintain high standards in publication and peer review, driving innovation and discovery in the fields it represents.

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Fostering Global Collaboration in Clinical Medicine
Publisher: WILEY-HINDAWIISSN: 1368-5031Frequency: 1 issue/year

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE is a premier peer-reviewed academic journal published by WILEY-HINDAWI, dedicated to advancing the field of clinical medicine. With an ISSN of 1368-5031 and E-ISSN 1742-1241, this open access journal has been providing a platform for insightful research since its inception in 1997 and continues to contribute significantly to the medical community, as indicated by its Q2 ranking in Medicine (miscellaneous) for 2023 and its position in the top 15% of Scopus-ranked journals. The journal invites innovative studies, systematic reviews, and clinical trials, making it a critical resource for healthcare professionals, researchers, and students seeking to stay updated on the latest clinical practices. Based in the United Kingdom at Adam House, 3rd Fl, 1 Fitzroy Sq, London W1T 5HE, this journal supports open accessibility, enhancing the dissemination of vital research findings across the globe. Join the growing community of scholars who contribute to and benefit from this influential publication as it continues to shape the future of clinical practice.

CLINICAL THERAPEUTICS

Transforming therapeutic strategies through rigorous research.
Publisher: ELSEVIERISSN: 0149-2918Frequency: 12 issues/year

Clinical Therapeutics, published by Elsevier, is a highly esteemed peer-reviewed journal that has been pivotal in advancing the field of pharmacology since its inception in 1977. With an impressive impact factor and recognition as Q2 in Pharmacology and Q1 in Medical Pharmacology for 2023, it stands at the forefront of research and discussions on innovative therapeutic strategies and pharmacological advancements. This journal not only caters to a broad audience of researchers and clinicians but also plays a vital role in disseminating critical information that supports the enhancement of patient care and safety. As a repository of high-quality, evidence-based articles, Clinical Therapeutics is a crucial resource for those involved in drug development, medical research, and clinical practice, making it an essential read for anyone dedicated to improving health outcomes through pharmaceutical sciences.

SINGAPORE MEDICAL JOURNAL

Exploring the forefront of medical research and practice.
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 0037-5675Frequency: 12 issues/year

The SINGAPORE MEDICAL JOURNAL, published by Wolters Kluwer Medknow Publications, stands as a prominent platform dedicated to advancing the field of general medicine. With an established history dating back to 1960, this esteemed journal has been at the forefront of medical research, fostering innovation and the dissemination of knowledge within a diverse medical community. It is currently ranked in the Q3 category for medicine (miscellaneous), with a commendable 75th percentile ranking in Scopus among its peers. The journal features a broad range of research, clinical trials, and reviews, serving as an essential resource for researchers, healthcare professionals, and students eager to stay abreast of the latest developments in medicine. Although it does not currently offer open access, its commitment to high-quality scholarship and rigorous peer-review processes solidifies its role as a vital academic resource. With an ISSN of 0037-5675 and an E-ISSN of 2737-5935, the SINGAPORE MEDICAL JOURNAL is dedicated to enhancing the scientific dialogue within the global healthcare landscape.

International Journal of Clinical and Experimental Medicine

Championing Excellence in Peer-Reviewed Research
Publisher: E-CENTURY PUBLISHING CORPISSN: 1940-5901Frequency: 12 issues/year

International Journal of Clinical and Experimental Medicine, an esteemed publication by E-CENTURY PUBLISHING CORP, serves as a vital resource for researchers and professionals in the fields of biochemistry, genetics, and molecular biology. Since its inception in 2009 and continuing until 2017, the journal has presented a wealth of knowledge aimed at fostering innovation and collaboration within the scientific community. Although the coverage has been discontinued in Scopus, the journal has established itself within the academic discourse, evidenced by its ranking in the 28th percentile for General Biochemistry, Genetics and Molecular Biology. As an open-access publication, it ensures widespread dissemination of research findings, making it a crucial platform for the advancement of clinical and experimental medicine. With its commitment to high-quality peer-reviewed articles, the International Journal of Clinical and Experimental Medicine remains a significant contribution to the body of knowledge in its field, serving as an invaluable tool for students, researchers, and practitioners alike.

Precision Clinical Medicine

Elevating clinical practice through precision insights.
Publisher: OXFORD UNIV PRESSISSN: 2096-5303Frequency: 4 issues/year

Precision Clinical Medicine, published by Oxford University Press, is an esteemed open-access journal that has been at the forefront of clinical research since its inception in 2018. With an ISSN of 2096-5303, this journal specializes in the rapidly evolving field of precision medicine, which aims to tailor healthcare to individual patient characteristics, needs, and preferences. As a testament to its influence, Precision Clinical Medicine holds a remarkable rank of #34 out of 636 in the General Medicine category on Scopus, placing it within the 94th percentile of its field and earning a prestigious Q1 rating in 2023. Based in the United Kingdom, the journal not only provides open access content, ensuring that groundbreaking research is widely disseminated, but also serves as a crucial platform for innovations and discussions that shape modern medical practices. Researchers, professionals, and students alike will find valuable insights and influential studies that drive the future of personalized healthcare within its pages.

JBJS Reviews

Transforming Research into Practice for Better Outcomes.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 2329-9185Frequency: 12 issues/year

JBJS Reviews is a premier academic journal published by Lippincott Williams & Wilkins, dedicated to the fields of Orthopedics, Sports Medicine, and Surgery. With an impactful presence in the medical community, the journal is recognized for its high-quality and peer-reviewed content that boasts an impressive ranking, including a Q1 quartile status in both Orthopedics and Surgery as of 2023. This esteemed publication is indexed in Scopus, achieving a rank of #115 out of 551 in Medicine Surgery and #88 out of 321 in Medicine Orthopedics and Sports Medicine. Since its inception in 2014, JBJS Reviews has served as a critical platform for advancing knowledge and fostering innovation, offering researchers, professionals, and students valuable insights into the latest advancements, evidence-based practices, and trends in the orthopedic field. Although not currently offering open access, JBJS Reviews remains a pivotal resource for those aiming to stay at the forefront of orthopedic and surgical excellence.

Precision and Future Medicine

Pioneering research for a personalized medical landscape.
Publisher: SUNGKYUNKWAN UNIV SCH MEDICINEISSN: 2508-7940Frequency: 4 issues/year

Precision and Future Medicine is an esteemed academic journal published by Sungkyunkwan University School of Medicine, dedicated to advancing the fields of precision medicine and healthcare innovation. Established as an Open Access journal in 2017, it aims to disseminate cutting-edge research and insights that bridge the gap between basic and clinical sciences. With a focus on personalized medicine, genomics, and advanced therapeutic strategies, the journal serves as a vital resource for researchers, clinicians, and policy makers. Set in the dynamic environment of South Korea, Precision and Future Medicine provides a platform for the exchange of ideas that are shaping the future of medical science, thus contributing significantly to the global dialogue on health and wellness. As it continues to grow, the journal is committed to ensuring that high-quality research remains accessible to all, fostering a spirit of collaboration and innovation within the scientific community.

SEMINARS IN RADIATION ONCOLOGY

Empowering Cancer Treatment through Innovative Research
Publisher: W B SAUNDERS CO-ELSEVIER INCISSN: 1053-4296Frequency: 4 issues/year

SEMINARS IN RADIATION ONCOLOGY is a premier journal published by W B SAUNDERS CO-ELSEVIER INC, dedicated to advancing the field of radiation oncology through high-quality research and comprehensive reviews. With an impressive impact factor and a notable HIndex, this journal holds a prominent place within the academic community, particularly illustrated by its Q2 ranking in both Cancer Research and Oncology, and a Q1 ranking in Radiology, Nuclear Medicine, and Imaging as of 2023. Since its inception in 1991, the journal has served as a vital resource for researchers, clinicians, and healthcare professionals, facilitating the exchange of innovative ideas and practices that shape the future of cancer treatment. While the journal is not open access, it offers essential insights into the latest advancements in the field, catering to a diverse audience eager to expand their knowledge and improve patient outcomes in the realm of radiation therapy.